BBHvsIYH
VanEck Biotech ETF against iShares U.S. Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBH | IYH | |
|---|---|---|
| Expense ratio | 0.35% | 0.40% |
| Assets | $483M | $4B |
| Net flow, 1 month | −$5M | +$337M |
| Net flow, 1 year | −$21M | +$576M |
| Return, YTD | +24.9% | +8.6% |
| Return, 1 year | +35.7% | +16.1% |
| Avg daily volume | 10K | 619K |
| Holdings | 26 | 117 |
| Listed | Nov 23, 1999 | Jun 12, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS